• 2080 Citations
  • 25 h-Index
1988 …2020
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Alexander Fossa is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Hodgkin Disease Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Survivors Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
Non-Hodgkin's Lymphoma Medicine & Life Sciences
Stem Cell Transplantation Medicine & Life Sciences
Second Primary Neoplasms Medicine & Life Sciences
Prostatic Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1988 2020

  • 2080 Citations
  • 25 h-Index
  • 63 Article
  • 2 Letter

Brentuximab vedotin in relapsed or refractory classical hodgkin lymphoma: real life experience in Norway 2011–2016

Fosså, A., Smeland, K., Fagerli, U. M., Galleberg, R. B., Bersvendsen, H. S. & Holte, H., Jan 2 2020, In : Acta Oncologica. 59, 1, p. 101-105 5 p.

Research output: Contribution to journalLetter

Life Change Events
Hodgkin Disease
1 Citation (Scopus)

Chronic fatigue is highly prevalent in survivors of autologous stem cell transplantation and associated with IL-6, neuroticism, cardiorespiratory fitness, and obesity

Smeland, K. B., Loge, J. H., Aass, H. C. D., Aspelin, T., Bersvendsen, H., Bolstad, N., Fagerli, U. M., Falk, R. S., Fluge, Ø., Fossa, A., Holte, H., Lund, M. B., Murbræch, K., Reinertsen, K. V., Stenehjem, J. S. & Kiserud, C. E., Apr 1 2019, In : Bone marrow transplantation. 54, 4, p. 607-610 4 p.

Research output: Contribution to journalLetter

Stem Cell Transplantation
Cardiorespiratory Fitness

No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy

Lagerlöf, I., Holte, H., Glimelius, I., Björkholm, M., Enblad, G., Erlanson, M., Fluge, Ø., Fohlin, H., Fosså, A., Goldkuhl, C., Gustavsson, A., Johansson, A. S., Linderoth, J., Nome, O., Palma, M., Åkesson, L., Østenstad, B., Raud, C., Glimelius, B. & Molin, D., Jan 1 2019, (Accepted/In press) In : British Journal of Haematology.

Research output: Contribution to journalArticle

Hodgkin Disease
Drug Therapy
3 Citations (Scopus)

Relapse risk and loss of lifetime after modern combined modality treatment of young patients with Hodgkin lymphoma: A Nordic lymphoma epidemiology group study

Biccler, J. L., Glimelius, I., Eloranta, S., Smeland, K. B., de Nully Brown, P., Jakobsen, L. H., Frederiksen, H., Jerkeman, M., Fosså, A., Andersson, T. M. L., Holte, H., Bøgsted, M., El-Galaly, T. C. & Smedby, K. E., Mar 20 2019, In : Journal of Clinical Oncology. 37, 9, p. 703-713 11 p.

Research output: Contribution to journalArticle

Hodgkin Disease

Survivors’ knowledge of their diagnosis, treatment and possible late adverse effects after autologous stem cell transplantation for lymphoma

Simensen, V. C., Smeland, K. B., Kiserud, C. E., Dahl, A. A., Bersvendsen, H. S., Fluge, Ø., Fagerli, U. M. & Fosså, A., Sep 2 2019, In : Acta Oncologica. 58, 9, p. 1315-1322 8 p.

Research output: Contribution to journalArticle

Stem Cell Transplantation
Cell- and Tissue-Based Therapy
Stem Cells